Developing Story: Triple Negative MBC - Hard Truths, Real Hope with Dr Sarah Premji
Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast

Developing Story: Triple Negative MBC - Hard Truths, Real Hope with Dr Sarah Premji

Triple negative metastatic breast cancer has long been considered the hardest subtype to treat. That is changing and faster than most patients realize. Dr. Sarah Premji joins Victoria Goldberg to break down two landmark FDA approvals, the science behind antibody-drug conjugates, and what's coming next in the pipeline

Read More
Developing Story: Beyond Camizestrant — The Evolving Landscape of ER+/HER2- MBC with Dr. Sarah Premji
Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast

Developing Story: Beyond Camizestrant — The Evolving Landscape of ER+/HER2- MBC with Dr. Sarah Premji

The oral SERD era has arrived, and the treatment landscape for HR+/HER2- metastatic breast cancer is changing fast. Hosts Victoria Goldberg and Abigail Johnston sit down with Dr. Sarah Premji of Sarah Cannon to map out what has shifted beyond SERENA-6, from new FDA approvals and emerging mechanisms to real-world sequencing decisions and the latest trial data. If you are trying to make sense of a rapidly evolving algorithm, this episode is for you.

Read More